These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acute hepatitis C virus infection, 1986-2001: a rare cause of fulminant hepatitis in Chiba, Japan. Kanda T, Yokosuka O, Imazeki F, Saisho H. Hepatogastroenterology; 2004; 51(56):556-8. PubMed ID: 15086201 [Abstract] [Full Text] [Related]
26. A case of non A, non B, non C hepatitis that relapsed into fulminant hepatic failure. Cuffari C, Brochu P, Russo P, Alvarez F. Hepatogastroenterology; 1998; 45(24):2348-51. PubMed ID: 9951921 [Abstract] [Full Text] [Related]
32. Fulminant hepatic failure: an unusual presentation of metastatic liver disease. Harrison HB, Middleton HM, Crosby JH, Dasher MN. Gastroenterology; 1981 Apr; 80(4):820-5. PubMed ID: 7202952 [Abstract] [Full Text] [Related]
33. Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8 T lymphocytes in fulminant hepatitis B. Kondo Y, Kobayashi K, Asabe S, Shiina M, Niitsuma H, Ueno Y, Kobayashi T, Shimosegawa T. Liver Int; 2004 Dec; 24(6):561-7. PubMed ID: 15566505 [Abstract] [Full Text] [Related]
34. An improved model of galactosamine-induced fulminant hepatic failure in the pig. Kalpana K, Ong HS, Soo KC, Tan SY, Prema Raj J. J Surg Res; 1999 Apr; 82(2):121-30. PubMed ID: 10090819 [Abstract] [Full Text] [Related]
35. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Ryo K, Kamogawa Y, Ikeda I, Yamauchi K, Yonehara S, Nagata S, Hayashi N. Am J Gastroenterol; 2000 Aug; 95(8):2047-55. PubMed ID: 10950056 [Abstract] [Full Text] [Related]